GB2090135A - A Composition for the Topical Treatment of Acne - Google Patents

A Composition for the Topical Treatment of Acne Download PDF

Info

Publication number
GB2090135A
GB2090135A GB8119333A GB8119333A GB2090135A GB 2090135 A GB2090135 A GB 2090135A GB 8119333 A GB8119333 A GB 8119333A GB 8119333 A GB8119333 A GB 8119333A GB 2090135 A GB2090135 A GB 2090135A
Authority
GB
United Kingdom
Prior art keywords
composition
composition according
peroxide
erythromycin
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8119333A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rorer International Overseas Inc
Original Assignee
Rorer International Overseas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer International Overseas Inc filed Critical Rorer International Overseas Inc
Priority to IE287481A priority Critical patent/IE52227B1/en
Publication of GB2090135A publication Critical patent/GB2090135A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38Percompounds, e.g. peracids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB8119333A 1980-12-08 1981-06-23 A Composition for the Topical Treatment of Acne Withdrawn GB2090135A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE287481A IE52227B1 (en) 1980-12-08 1981-12-08 A composition for the topical treatment of acne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21412480A 1980-12-08 1980-12-08

Publications (1)

Publication Number Publication Date
GB2090135A true GB2090135A (en) 1982-07-07

Family

ID=22797872

Family Applications (2)

Application Number Title Priority Date Filing Date
GB8119333A Withdrawn GB2090135A (en) 1980-12-08 1981-06-23 A Composition for the Topical Treatment of Acne
GB8136777A Expired GB2088717B (en) 1980-12-08 1981-12-07 A composition for the topical treatment of acne

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8136777A Expired GB2088717B (en) 1980-12-08 1981-12-07 A composition for the topical treatment of acne

Country Status (18)

Country Link
JP (1) JPS5799525A (xx)
AR (1) AR229405A1 (xx)
AT (1) AT381452B (xx)
AU (1) AU557147B2 (xx)
BE (1) BE889327A (xx)
CA (1) CA1179599A (xx)
CH (2) CH647147A5 (xx)
DE (1) DE3124698A1 (xx)
DK (1) DK273981A (xx)
ES (1) ES8303087A1 (xx)
FR (1) FR2495471A1 (xx)
GB (2) GB2090135A (xx)
IT (1) IT1210608B (xx)
NL (1) NL8102997A (xx)
NZ (1) NZ197491A (xx)
PH (1) PH19245A (xx)
SE (1) SE8103925L (xx)
ZA (1) ZA814215B (xx)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0209724A2 (de) * 1985-06-18 1987-01-28 Biogal Gyogyszergyar Präparat mit Wirkung gegen Akne sowie Verwendung von Wirkstoffextrakt des Queckenweizens
EP0291960A2 (en) * 1987-05-19 1988-11-23 Yakurigaku Chuo Kenkyusho Novel synthetic aluminum silicate preparation
WO1993020796A1 (en) * 1992-04-09 1993-10-28 Allergan, Inc. Method and composition for treating acne
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
WO1995031978A1 (en) * 1994-05-19 1995-11-30 The Procter & Gamble Company Anti-acne compositions
US6495158B1 (en) 2001-01-19 2002-12-17 Lec Tec Corporation Acne patch
WO2011070170A1 (en) 2009-12-10 2011-06-16 Galderma Research & Development Novel peroxide derivatives, their process of preparation and their use in human medicine and in cosmetics for the treatment or prevention of acne
WO2011070171A1 (en) 2009-12-10 2011-06-16 Galderma Research & Development Derivatives of novel peroxides, method of preparation thereof and use thereof in human medicine as well as in cosmetics for the treatment or prevention of acne

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3375376D1 (en) * 1982-10-15 1988-02-25 Procter & Gamble Storage stable topical pharmaceutical composition including nitrogen-containing stabilizers
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
FR2558372B1 (fr) * 1984-01-25 1987-08-07 Oreal Composition medicamenteuse pour le traitement de l'acne
FR2604357B1 (fr) * 1986-09-30 1988-12-02 Oreal Composition pharmaceutique et cosmetique anti-acneique
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
JP2001509477A (ja) * 1997-07-08 2001-07-24 デーエスエム・ナムローゼ・フェンノートシャップ ベンゾイルペルオキシドと第二活性成分との組合せの局所適用
DE19917548A1 (de) * 1999-04-19 2000-10-26 August Wolff Gmbh & Co Arzneim Pharmazeutische Zusammensetzung auf der Basis von Erythromycin-Fettsäuresalzen mit 12 bis 22 Kohlenstoffatomen im Fettsäurerest und Verwendung dieser Erythromycin-Fettsäuresalze zur topischen Behandlung von Hauterkrankungen
AU2001275201A1 (en) * 2000-06-02 2001-12-11 Dermik International Holding Inc. Acne-treating composition
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
CA2600762C (en) * 2005-03-10 2011-05-31 Jr Chem, Llc Stable organic peroxide compositions
US9107844B2 (en) 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
CA2656451C (en) * 2006-07-13 2015-01-27 Galderma Research & Development Composition comprising a retinoid and benzoyl peroxide
FR2903604B1 (fr) * 2006-07-13 2008-09-05 Galderma Res & Dev S N C Snc Composition comprenant un retinoide et du peroxyde de benzoyle
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
US8288434B2 (en) * 2008-06-05 2012-10-16 Dow Pharmaceutical Sciences, Inc. Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
JP6525074B2 (ja) 2017-07-31 2019-06-05 大日本印刷株式会社 熱転写シート、印画シートと熱転写シートとの組合せ、及び熱転写印画装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368949A1 (fr) * 1976-11-01 1978-05-26 Procter & Gamble Produit antimicrobien a base d'erythromycine pour le traitement topique des affections acneiques
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0209724A2 (de) * 1985-06-18 1987-01-28 Biogal Gyogyszergyar Präparat mit Wirkung gegen Akne sowie Verwendung von Wirkstoffextrakt des Queckenweizens
EP0209724A3 (en) * 1985-06-18 1988-07-06 Biogal Gyogyszergyar Preparation effective against acne and the use of an active extract of couch grass
EP0291960A2 (en) * 1987-05-19 1988-11-23 Yakurigaku Chuo Kenkyusho Novel synthetic aluminum silicate preparation
EP0291960A3 (en) * 1987-05-19 1990-09-12 Yakurigaku Chuo Kenkyusho Kk Novel synthetic aluminum silicate preparation
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
WO1993020796A1 (en) * 1992-04-09 1993-10-28 Allergan, Inc. Method and composition for treating acne
WO1995031978A1 (en) * 1994-05-19 1995-11-30 The Procter & Gamble Company Anti-acne compositions
CN1079669C (zh) * 1994-05-19 2002-02-27 赫英尔柯特赫尔曼两合公司 防痤疮组合物
US6495158B1 (en) 2001-01-19 2002-12-17 Lec Tec Corporation Acne patch
WO2011070170A1 (en) 2009-12-10 2011-06-16 Galderma Research & Development Novel peroxide derivatives, their process of preparation and their use in human medicine and in cosmetics for the treatment or prevention of acne
WO2011070171A1 (en) 2009-12-10 2011-06-16 Galderma Research & Development Derivatives of novel peroxides, method of preparation thereof and use thereof in human medicine as well as in cosmetics for the treatment or prevention of acne
US9102607B2 (en) 2009-12-10 2015-08-11 Galderma Research & Development Peroxide derivatives, their process of preparation and their use in human medicine and in cosmetics for the treatment or prevention of acne

Also Published As

Publication number Publication date
ATA285581A (de) 1986-03-15
NZ197491A (en) 1985-02-28
CH647147A5 (de) 1985-01-15
ZA814215B (en) 1983-02-23
CA1179599A (en) 1984-12-18
DE3124698A1 (de) 1982-07-08
DE3124698C2 (xx) 1992-06-25
AT381452B (de) 1986-10-27
GB2088717B (en) 1984-12-12
DK273981A (da) 1982-09-09
ES503797A0 (es) 1983-03-01
PH19245A (en) 1986-02-14
CH656307A5 (de) 1986-06-30
NL8102997A (nl) 1982-07-01
JPS5799525A (en) 1982-06-21
AU7202981A (en) 1982-06-17
GB2088717A (en) 1982-06-16
BE889327A (fr) 1981-10-16
SE8103925L (sv) 1982-06-09
AR229405A1 (es) 1983-08-15
AU557147B2 (en) 1986-12-11
ES8303087A1 (es) 1983-03-01
IT8167845A0 (it) 1981-06-18
FR2495471A1 (fr) 1982-06-11
IT1210608B (it) 1989-09-14

Similar Documents

Publication Publication Date Title
US4497794A (en) Erythromycin/benzoyl peroxide composition for the treatment of acne
US4692329A (en) Erythromycin/benzoyl peroxide antiacne compositions
CA1179599A (en) Pharmaceutical preparations
EP0499399B1 (en) Analgesic compositions
US4056611A (en) Therapeutic composition
US5122519A (en) Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
KR100283793B1 (ko) 지루 및/또는 여드름 치료의 유효성분으로서 화장품 및/또는 피부과학적 조성물에 사용되는 옥트옥시글리세롤의 용도
EP1856237B1 (en) Stable organic peroxide compositions
JP3513873B2 (ja) 皮膚外用剤
EP0215108B1 (en) Compositions for treating acne vulgaris and methods of making same
EP0093186B1 (en) Pharmaceutical preparation for the topical treatment of acne
RU2543644C2 (ru) Композиция для личной гигиены, содержащая летучее вещество и терпеновый спирт
EP0402933B2 (en) Use of sucralfate humid gel as vehicle for drugs having topic activity and for cosmetics
CA1156558A (en) Stable benzoyl peroxide composition
US20050123576A1 (en) Mupirocin compositions for topical use, an improved process of making same and methods of using same
US20110021447A1 (en) Acne treatment composition and methods for using
US6203804B1 (en) External skin-care composition
IE52227B1 (en) A composition for the topical treatment of acne
US20230037905A1 (en) Topical composition comprising tofacitinib and fingolimod
NZ209389A (en) Topical acne treatment composition
US8299122B2 (en) Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition
JP2000128763A (ja) 抗菌剤組成物及びこれを含有する皮膚外用剤
JPH1149696A (ja) 紫外線皮膚免疫機能低下防止用免疫賦活剤
KR100283044B1 (ko) 지루 및/또는 여드름 치료의 유효 성분으로서 화장품 및/또는 피부과학적 조성물에 사용되는 옥트옥시글리세롤의 용도

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)